OpenLB
Open Library of Bioscience
Advanced Search
British journal of pharmacology
Sep, 2014;171 (17): 3961-2.

Special issue of BJP on nanomedicine.

Andrew Owen
Author Information
  1. Andrew Owen: Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, L693GF, UK; MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, L69 3GE, UK; Tandem Nano Ltd., Foundation Building, 765 Brownlow Hill, Liverpool, L69 7ZX, UK.
PMID: 25113563 DOI: 10.1111/bph.12820

Abstract

No abstract text available.

References

  1. Blood. 1964 Mar;23:354-8 [PMID: 14130446]
  2. Br J Pharmacol. 2014 Sep;171(17):3980-7 [PMID: 24111818]
  3. Br J Pharmacol. 2014 Sep;171(17):3963-79 [PMID: 24467481]
  4. Drugs. 2014 Jan;74(1):7-13 [PMID: 24327298]
  5. Br J Pharmacol. 2014 Sep;171(17):3988-4000 [PMID: 24724793]
  6. J Drug Deliv. 2012;2012:389485 [PMID: 22506121]
  7. Health Forum J. 1999 Jul-Aug;42(4):32, 36-7 [PMID: 10539018]
  8. Drugs Today (Barc). 2010 Jul;46(7):463-71 [PMID: 20683501]
  9. Br J Pharmacol. 2014 Sep;171(17):4001-9 [PMID: 24571489]
  10. Int J Nanomedicine. 2008;3(3):295-309 [PMID: 18990939]
  11. Adv Drug Deliv Rev. 2014 Feb;66:2-25 [PMID: 24270007]

Grants

  1. G0800247/Medical Research Council

MeSH Term

Nanomedicine
Editorial Introductory Journal Article
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0SpecialissueBJPnanomedicine

Similar Articles

Cited By